Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Publications

Publications


Search

Fill in your search phrase.
Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Journal Article (11806)
  • Report (9272)

Publicatiejaar

Selecting an option will change the focus to the start of the list.
  • 2026 (250)
  • 2025 (699)
  • 2024 (966)
  • 2023 (863)
  • 2022 (938)
  • 2021 (537)
  • 2020 (144)
  • 2019 (158)
  • 2018 (789)
  • 2017 (932)
  • 2016 (1002)
  • 2015 (1056)
  • 2014 (984)
  • 2013 (1045)
  • 2012 (1094)
  • 2011 (1189)
  • 2010 (250)
  • 2009 (256)
  • 2008 (234)
  • 2007 (175)
  • 2006 (131)
  • 2005 (144)
  • 2004 (172)
  • 2003 (175)
  • 2002 (226)
  • 2001 (251)
  • 2000 (158)
  • 1999 (215)
  • 1998 (204)
  • 1997 (234)
  • 1996 (288)
  • 1995 (351)
  • 1994 (321)
  • 1993 (355)
  • 1992 (289)
  • 1991 (255)
  • 1990 (284)
  • 1989 (306)
  • 1988 (250)
  • 1987 (248)
  • 1986 (246)
  • 1985 (216)
  • 1984 (199)
  • 1983 (3)
  • 1982 (2)
  • 1980 (3)
  • 1978 (1)

Restrisico voor Nederlandse publieke beroepsmatige grenswaarden afgeleid volgens de risicobenadering

LJ Engel, JAB Kettelarij

In de Arbeidsomstandighedenregeling staan de publieke grenswaarden voor gevaarlijke stoffen op het werk. Voor sommige stoffen bestaat geen veilige ondergrens. In theorie kan één molecuul al effect…

27-05-2026

Report

Meningococcal disease serogroup B. Updated information for the Dutch Health Council

MJ Knol, LL Montessori

Meningokokkenziekte is een levensbedreigende ziekte die door verschillende typen meningokokkenbacteriën (serogroepen) wordt veroorzaakt. Deze serogroepen zijn met letters aangegeven. In Nederland…

20-05-2025

Report

Challenges in human micro- and nanoplastic risk assessment: stocktaking and the road ahead

D Kühnel, A Jemec Kokalj, AFRM Ramsperger, D Drobne, A Undas, WJGM Peijnenburg, et al.

Journal Article

Current state and potential of hospitals for automated healthcare-associated infection surveillance: data from 24 European countries, 2022 to 2023

FD Rüther, M Guedes, E Presterl, C Suetens, D Plachouras, S van Rooden, et al.

Journal Article

Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023

M Bertran, B de Gier, TG Vilaplana, NM van Sorge, HE de Melker, A Steens

Journal Article

Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024

KT Veldman, A van Essen-Zandbergen, Y Geurts, F Harders, B Wit, APA Hendrickx, et al.

Journal Article

Moderating role of supervisor support in the association between job demands and distress: a mixed-effects analysis in a population-based cohort study

HAM Lettinga, K I Proper, MF van Wier, SE Kramer, SH van Oostrom, JR Anema

Journal Article

Modelling NO2 concentrations around the city of Utrecht (the Netherlands) with uEMEP: comparison with measurements and Dutch monitoring results [PRESENTATION]

SC van der Graaf, P Witsenboer, J Wesseling, E van der Swaluw

Journal Article

Untargeted metabolomic profiling of childhood asthma: An exploratory analysis of anthropogenic chemicals and the serum metabolome

MJ Oosterwegel, D Ibi, U Gehring, GH Koppelman, JM Vonk, JMA Boer, et al.

Journal Article

Maternal Group B Streptococcus Vaccination: A Three-Country European Consortium to Improve Surveillance and Data Readiness

E Horváth-Puhó, T Lamagni, PT Heath, MW Bijlsma, M Risager Lykke, B de Gier, et al.

Journal Article

Pagination

  • « « First
  • ‹ ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • › Next ›
  • » Last »

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Social media house rules

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon